This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gambelunghe, G. Articles by Sanjeevi, C. B. Search for Related Content PubMed PubMed Citation Articles by Gambelunghe, G. Articles by Sanjeevi, C. B. Pubmed/NCBI databases OMIM Substance via MeSH Medline Plus Health Information Addison's Disease Autoimmune Diseases

Microsatellite Polymorphism of the MHC Class I Chain-Related (MIC-A and MIC-B) Genes Marks the Risk for Autoimmune Addison’s Disease

Immunology and Immunogenetics Laboratory, Department of Internal Medicine and Endocrine and Metabolic Sciences (G.G., A.F., S.L., C.T., F.S., P.B.), University of Perugia, I-06126 Perugia, Italy; and Department of Molecular Medicine (G.G., M.G., C.B.S.), Karolinska Institute, S-17176 Stockholm, Sweden

Address correspondence and requests for reprints to: Carani B. Sanjeevi, M.D., Ph.D., Department of Molecular Medicine, Karolinska Hospital, CMM L8:03, S-171 76 Stockholm, Sweden. E-mail: sanjeevi.carani{at}molmed.ki.se

The major histocompatibility complex class I chain-related MIC-A and MIC-B genes are located on chromosome 6 between the histocompatibility leucocyte antigen (HLA)-B and the B-associated transcript genes. The presence of 21-hydroxylase autoantibodies is a sensitive and specific marker of autoimmune Addison’s disease. We studied the polymorphism of exon 5 of the MIC-A gene, of intron 1 of the MIC-B gene, and of HLA-DRB1, -DQA1, and -DQB1 genes in 28 autoimmune (21-hydroxylase autoantibody positive) Addison’s disease patients and in 75 healthy subjects from central Italy. The MIC-A5.1 allele was significantly more frequent in Addison’s disease patients (79%) than in healthy subjects (36%) [odds ratio (OR) = 6.52, corrected P (Pc) = 0.0015], whereas MIC-A6 was significantly reduced in affected subjects (15% vs. 56%, OR = 0.13, Pc = 0.002). The A5.1/A5.1 genotype had an OR for autoimmune Addison’s disease as high as 18.0 and an absolute risk of 1 per 1131. In the presence of MIC-A5.1, MICB-CA-25 was significantly increased in Addison’s disease patients (25% vs. 4%, OR = 8.0, P = 0.0039, Pc = 0.047). The MICB-CA-17 allele was absent in Addison’s disease patients, but present in more than 25% healthy individuals (OR = 0.10, P = 0.0025, Pc = 0.03). Among HLA-DR and -DQ haplotypes, only DRB1*03-DQA1*0501-DQB1*0201 (DR3/DQ2) was significantly more frequent in Addison’s disease patients than in healthy subjects, but only in the presence of MIC-A5.1. The frequency of MIC-A5.1 was significantly increased in Addison’s disease patients only in the presence of HLA-DR3-DQ2. Our study demonstrates that susceptibility to autoimmune Addison’s disease is linked to the MIC-A microsatellite allele 5.1 and that both MIC-A5.1 and HLA-DR3/DQ2 are necessary to confer increased genetic risk for Addison’s disease.

This article has been cited by other articles:

				T. M. Triolo, E. E. Baschal, T. K. Armstrong, C. S. Toews, P. R. Fain, M. J. Rewers, L. Yu, D. Miao, G. S. Eisenbarth, P. A. Gottlieb, et al. Homozygosity of the Polymorphism MICA5.1 Identifies Extreme Risk of Progression to Overt Adrenal Insufficiency among 21-Hydroxylase Antibody-Positive Patients with Type 1 Diabetes J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4517 - 4523. [Abstract] [Full Text] [PDF]

				A. N. Hasan, W. J. Kollen, D. Trivedi, A. Selvakumar, B. Dupont, M. Sadelain, and R. J. O'Reilly A Panel of Artificial APCs Expressing Prevalent HLA Alleles Permits Generation of Cytotoxic T Cells Specific for Both Dominant and Subdominant Viral Epitopes for Adoptive Therapy J. Immunol., August 15, 2009; 183(4): 2837 - 2850. [Abstract] [Full Text] [PDF]

				M. Dittmar, M. Ide, M. Wurm, and G. J Kahaly Early onset of polyglandular failure is associated with HLA-DRB1*03. Eur. J. Endocrinol., July 1, 2008; 159(1): 55 - 60. [Abstract] [Full Text] [PDF]

				Z Gombos, R Hermann, M Kiviniemi, S Nejentsev, K Reimand, V Fadeyev, P Peterson, R Uibo, and J Ilonen Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations Eur. J. Endocrinol., December 1, 2007; 157(6): 757 - 761. [Abstract] [Full Text] [PDF]

				M. Ghaderi, G. Gambelunghe, C. Tortoioli, A. Brozzetti, K. Jatta, B. Gharizadeh, A. De Bellis, F. Pecori Giraldi, M. Terzolo, C. Betterle, et al. MHC2TA Single Nucleotide Polymorphism and Genetic Risk for Autoimmune Adrenal Insufficiency J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4107 - 4111. [Abstract] [Full Text] [PDF]

				G. Gambelunghe, R. Gerli, E. Bartoloni Bocci, P. Del Sindaco, M. Ghaderi, C. B. Sanjeevi, O. Bistoni, V. Bini, and A. Falorni Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus Rheumatology, March 1, 2005; 44(3): 287 - 292. [Abstract] [Full Text] [PDF]

				J. M. Barker, A. Ide, C. Hostetler, L. Yu, D. Miao, P. R. Fain, G. S. Eisenbarth, and P. A. Gottlieb Endocrine and Immunogenetic Testing in Individuals with Type 1 Diabetes and 21-Hydroxylase Autoantibodies: Addison's Disease in a High-Risk Population J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 128 - 134. [Abstract] [Full Text] [PDF]

				G. S. Eisenbarth and P. A. Gottlieb Autoimmune Polyendocrine Syndromes N. Engl. J. Med., May 13, 2004; 350(20): 2068 - 2079. [Full Text] [PDF]

				M. Dittmar and G. J. Kahaly Polyglandular Autoimmune Syndromes: Immunogenetics and Long-Term Follow-Up J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 2983 - 2992. [Abstract] [Full Text] [PDF]

				C. Betterle, C. Dal Pra, F. Mantero, and R. Zanchetta Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction Endocr. Rev., June 1, 2002; 23(3): 327 - 364. [Abstract] [Full Text] [PDF]

				M. Halonen, P. Eskelin, A.-G. Myhre, J. Perheentupa, E. S. Husebye, O. Kampe, F. Rorsman, L. Peltonen, I. Ulmanen, and J. Partanen AIRE Mutations and Human Leukocyte Antigen Genotypes as Determinants of the Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Phenotype J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2568 - 2574. [Abstract] [Full Text] [PDF]

				A Lopez-Vazquez, L Rodrigo, D Fuentes, S Riestra, C Bousono, S Garcia-Fernandez, J Martinez-Borra, S Gonzalez, and C Lopez-Larrea MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201 Gut, March 1, 2002; 50(3): 336 - 340. [Abstract] [Full Text] [PDF]

				G. Gambelunghe, M. Ghaderi, C. Tortoioli, A. Falorni, F. Santeusanio, P. Brunetti, C. B. Sanjeevi, and A. Falorni Two Distinct MICA Gene Markers Discriminate Major Autoimmune Diabetes Types J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3754 - 3760. [Abstract] [Full Text] [PDF]

				Y. Park, H. Lee, C. B. Sanjeevi, and G. S. Eisenbarth MICA Polymorphism Is Associated With Type 1 Diabetes in the Korean Population Diabetes Care, January 1, 2001; 24(1): 33 - 38. [Abstract] [Full Text]